A detailed history of Bridgeway Capital Management, LLC transactions in Icad Inc stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 74,600 shares of ICAD stock, worth $117,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,600
Previous 74,600 -0.0%
Holding current value
$117,868
Previous $96,000 21.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.8 - $3.61 $134,280 - $269,306
74,600 New
74,600 $157,000
Q4 2021

Feb 14, 2022

SELL
$6.7 - $11.38 $168,170 - $285,638
-25,100 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$10.11 - $17.56 $9,099 - $15,803
-900 Reduced 3.46%
25,100 $270,000
Q1 2021

May 17, 2021

BUY
$12.57 - $21.22 $17,598 - $29,708
1,400 Added 5.69%
26,000 $552,000
Q2 2020

Aug 14, 2020

BUY
$6.63 - $12.85 $163,098 - $316,110
24,600 New
24,600 $246,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $40M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.